CXCR4 chemokine receptors, histone deacetylase inhibitors and acute lymphoblastic leukemia

References

• Pui C H. Childhood leukemias. N Engl J Med 1995; 332: 1618–1630
   PubMed Web of Science ®Google Scholar
• Reiter A, Schrappe M, Ludwig W D, Hiddemann W, Sauter S, Henze G, et al. Chemotherapy in 998 unselected childhood acute lymphoblastic-leukemia patients – results and conclusions of the Multicenter Trial All-Bfm-86. Blood 1994; 84: 3122–3133
   PubMed Web of Science ®Google Scholar
• Bleyer W A, Poplack D G. Prophylaxis and treatment of leukemia in the central nervous-system and other sanctuaries. Semin Oncol 1985; 12: 131–148
   PubMed Web of Science ®Google Scholar
• Liotta L A. Cancer – an attractive force in metastasis. Nature 2001; 410: 24–25
   PubMed Web of Science ®Google Scholar
• Murphy P M. Chemokines and the molecular basis of cancer metastasis. N Engl J Med 2001; 345: 833–835
   PubMed Web of Science ®Google Scholar
• Coussens L M, Werb Z. Inflammation and cancer. Nature 2002; 420: 860–867
   PubMed Web of Science ®Google Scholar
• Baggiolini M. Chemokines and leukocyte traffic. Nature 1998; 392: 565–568
   PubMed Web of Science ®Google Scholar
• Horuk R. Chemokine receptors. Cytokine Growth Factor Rev 2001; 12: 313–335
   PubMed Web of Science ®Google Scholar
• Nomura H, Nielsen B W, Matsushima K. Molecular-cloning ofcDNAs encoding a LD78 receptor and putative leukocyte chemotactic peptide receptors. Int Immunol 1993; 5: 1239–1249
   PubMed Web of Science ®Google Scholar
• Jazin E E, Yoo H Y, Blomqvist A G, Yee F, Weng G H, Walker M W, et al. A proposed bovine neuropeptide-y (NPY) receptor cDNA clone, or its human homolog, confers neither NPY binding-sites nor NPY responsiveness on transfected cells. Regulat Pept 1993; 47: 247–258
   PubMed Web of Science ®Google Scholar
• Loetscher M, Geiser T, Oreilly T, Zwahlen R, Baggiolini M, Moser B. Cloning of a human 7-transmembrane domain receptor, LESTR, that is highly expressed in leukocytes. J Biol Chem 1994; 269: 232–237
   PubMed Web of Science ®Google Scholar
• Bleul C C, Farzan M, Choe H, Parolin C, ClarkLewis I, Sodroski J, et al. lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 1996; 382: 829–833
   PubMed Web of Science ®Google Scholar
• Oberlin E, Amara A, Bachelerie F, Bessia C, Virelizier J L, ArenzanaSeisdedos F, et al. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 1996; 384: 288
   Web of Science ®Google Scholar
• Nagasawa T, Nakajima T, Tachibana K, Iizasa H, Bleul C C, Yoshie O, et al. Molecular cloning and characterization of a murine pre-B-cell growth-stimulating factor stromal cell-derived factor 1 receptor, a murine homolog of the human immunodeficiency virus 1 entry coreceptor fusin. Proc Natl Acad Sci USA 1996; 93: 14726–14729
   PubMed Web of Science ®Google Scholar
• Aiuti A, Tavian M, Cipponi A, Ficara F, Zappone E, Hoxie J, et al. Expression of CXCR4, the receptor for stromal cell-derived factor-1 on fetal and adult human lymphohematopoietic progenitors. Eur J Immunol 1999; 29: 1823–1831
   PubMed Web of Science ®Google Scholar
• Muller A, Homey B, Soto H, Ge N F, Catron D, Buchanan M E, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001; 410: 50–56
   PubMed Web of Science ®Google Scholar
• Zou Y R, Kottmann A H, Kuroda M, Taniuchi I, Littman D R. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 1998; 393: 595–599
   PubMed Web of Science ®Google Scholar
• Ratajczak M Z, Majka M, Kucia M, Drukala J, Pietrzkowski Z, Peiper S, et al. Expression of functional CXCR4 by muscle satellite cells and secretion of SDF-1 by muscle-derived fibroblasts is associated with the presence of both muscle progenitors in bone marrow and hematopoietic stem/progenitor cells in muscles. Stem Cells 2003; 21: 363–371
   PubMed Web of Science ®Google Scholar
• Stumm R K, Rummel J, Junker V, Culmsee C, Pfeiffer M, Krieglstein J, et al. A dual role for the SDF-1/CXCR4 chemokine receptor system in adult brain: isoform-selective regulation of SDF-1 expression modulates CXCR4-dependent neuronal plasticity and cerebral leukocyte recruitment after focal ischemia. J Neurosci 2002; 22: 5865–5878
   PubMed Web of Science ®Google Scholar
• Sadir R, Imberty A, Baleux F, Lortat-Jacob H. Heparan sulfate/heparin oligosaccharides protect stromal cell-derived factor-1 (SDF-1)/CXCL12 against proteolysis induced by CD26/dipeptidyl peptidase IV. J Biol Chem 2004; 279: 43854–43860
   PubMed Web of Science ®Google Scholar
• Ma Q, Jones D, Borghesani P R, Segal R A, Nagasawa T, Kishimoto T, et al. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc Natl Acad Sci USA 1998; 95: 9448–9453
   PubMed Web of Science ®Google Scholar
• Mohle R, Bautz F, Rafii S, Moore M AS, Brugger W, Kanz L. The chemokine receptor CXCR-4 is expressed on CD34( + ) hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1. Blood 1998; 91: 4523–4530
   PubMed Web of Science ®Google Scholar
• Mohle R, Failenschmid C, Bautz F, Kanz L. Overexpression of the chemokine receptor CXCR4 in B cell chronic lymphocytic leukemia is associated with increased functional response to stromal cell-derived factor-1 (SDF-1). Leukemia 1999; 13: 1954–1959
   PubMed Web of Science ®Google Scholar
• Burger J A, Kipps T J. Chemokine receptors and stromal cells in the homing and homeostasis of chronic lymphocytic leukemia B cells. Leuk Lymphoma 2002; 43: 461–466
   PubMed Web of Science ®Google Scholar
• Crazzolara R, Kreczy A, Mann G, Heitger A, Eibl G, Fink F M, et al. High expression of the chemokine receptor CXCR4 predicts extramedullary organ infiltration in childhood acute lymphoblastic leukaemia. Br J Haematol 2001; 115: 545–553
   PubMed Web of Science ®Google Scholar
• Schneider P, Vasse M, Al Bayati A, Lenormand B, Vannier J P. Is high expression of the chemokine receptor CXCR-4 of predictive value for early relapse in childhood acute lymphoblastic leukaemia?. Br J Haematol 2002; 119: 579–580
   PubMed Web of Science ®Google Scholar
• Bene M C, Castoldi G, Knapp W, Ludwig W D, Matutes E, Orfao A, et al. Proposals for the immunological classification of acute leukemias. Leukemia 1995; 9: 1783–1786
   PubMed Web of Science ®Google Scholar
• Corcione A, Ottonello L, Tortolina G, Facchetti P, Airoldi I, Guglielmino R, et al. Stromal cell-derived factor-1 as a chemoattractant for follicular center lymphoma B cells. J Natl Cancer Inst 2000; 92: 628–635
   PubMed Web of Science ®Google Scholar
• Arai J, Yasukawa M, Yakushijin Y, Miyazaki T, Fujita S. Stromal cells in lymph nodes attract B-lymphoma cells via production of stromal cell-derived factor-1. Eur J Haematol 2000; 64: 323–332
   PubMed Web of Science ®Google Scholar
• Juarez J, Bradstock K F, Gottlieb D J, Bendall L J. Effects of inhibitors of the chemokine receptor CXCR4 on acute lymphoblastic leukemia cells in vitro. Leukemia 2003; 17: 1294–1300
   PubMed Web of Science ®Google Scholar
• Paul S, Mancuso P, Rabascio C, Gobbi A, Capillo M, Pruneri G. vitro and preclinical activity of the novel AMD3100 CXCR4 antagonist in lymphoma models. American Society of Hematology Annual Meeting 2002. American Society of Hematology, Philadelphia, PennsylvaniaUSA 2002
   Google Scholar
• Cosgrove M S, Boeke J D, Wolberger C. Regulated nucleosome mobility and the histone code. Nat Struct Mol Biol 2004; 11: 1037–1043
   PubMed Web of Science ®Google Scholar
• Jenuwein T, Allis C D. Translating the histone code. Science 2001; 293: 1074–1080
   PubMed Web of Science ®Google Scholar
• Imhof A, Yang X J, Ogryzko V V, Nakatani Y, Wolffe A P, Ge H. Acetylation of general transcription factors by histone acetyltransferases. Curr Biol 1997; 7: 689–692
   PubMed Web of Science ®Google Scholar
• Thiagalingam S, Cheng K H, Lee H J, Mineva N, Thiagalingam A, Ponte J F. Histone deacetylases: unique players in shaping the epigenetic histone code. Ann NY Acad Sci 2003; 983: 84–100
   PubMed Web of Science ®Google Scholar
• Imhof A, Yang X J, Ogryzko V V, Nakatani Y, Wolffe A P, Ge H. Acetylation of general transcription factors by histone acetyltransferases. Curr Biol 1997; 7: 689–692
   PubMed Web of Science ®Google Scholar
• Astrand C, Klenka T, Wrange O, Belikov S. Trichostatin A reduces hormone-induced transcription of the MMTV promoter and has pleiotropic effects on its chromatin structure. Eur J Biochem 2004; 271: 1153–1162
   PubMedGoogle Scholar
• Bernhard D, Ausserlechner M J, Tonko M, Loffler M, Hartmann B L, Csordas A, et al. Apoptosis induced by the histone deacetylase inhibitor sodium butyrate in human leukemic lymphoblasts. FASEB J 1999; 13: 1991–2001
   PubMed Web of Science ®Google Scholar
• Crazzolara R, Johrer K, Johnstone R W, Greil R, Kofler R, Meister B, et al. Histone deacetylase inhibitors potently repress CXCR4 chemokine receptor expression and function in acute lymphoblastic leukaemia. Br J Haematol 2002; 119: 965–969
   Web of Science ®Google Scholar
• Marshall J, Rizvi N, Kauh J, Dahut W, Figuera M, Kang M. A phase I trial of depsipedptide (FR901228) in patients with advanced cancer. J Exp Ther Oncol 2002; 2: 325–232
   PubMedGoogle Scholar
• Sandor V, Bakke S, Robey R W, Kang M H, Blagosklonny M V, Bender J, et al. Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms. Clin Cancer Res 2002; 8: 718–728
   PubMed Web of Science ®Google Scholar